Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “CHRONIC HEPATITIS B”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00034359
What this trial is testing

Safety and Antiviral Activity Study of ACH-126,443 (Beta-L-Fd4C) in Treatment-naive Adults With Chronic Hepatitis B Virus Infection

Who this might be right for
Hepatitis B, Chronic
Alexion Pharmaceuticals, Inc. 79
Not applicableStudy completedNCT01066559
What this trial is testing

Improvement of Humoral Immune Response With Hemodialysis on BK-F Membrane: Correlation to Soluble CD40 Clearing

Who this might be right for
Chronic Renal FailureHumoral Immune Alterations
University Hospital, Bordeaux 27
Post-approval studies (Phase 4)UnknownNCT01595633
What this trial is testing

Switch From Adefovir to Tenofovir in Chronic Hepatitis B for Suboptimal Response to Adefovir-based Combination Therapy

Who this might be right for
Chronic Hepatitis B
Yonsei University 124
Not applicableUnknownNCT04864366
What this trial is testing

Efficacy and Safety of TAF for 48 Weeks in HBeAg Positive CHB Patients

Who this might be right for
Chronic Hepatitis B
Huashan Hospital 150
Testing effectiveness (Phase 2)UnknownNCT05045261
What this trial is testing

ANRS HB07 IP-Cure-B Proof of Concept (PoC) Clinical Trial. Educating the Liver Immune Environment Through TLR8 Stimulation Followed by NUC Discontinuation

Who this might be right for
Hepatitis B, Chronic
ANRS, Emerging Infectious Diseases 100
Large-scale testing (Phase 3)Ended earlyNCT00362505
What this trial is testing

Safety and Antiviral Activity of Clevudine in Patients Who Have Completed the L-FMAU-301 or L-FMAU-302 Trials

Who this might be right for
Hepatitis B
Bukwang Pharmaceutical
Testing effectiveness (Phase 2)Looking for participantsNCT07069569
What this trial is testing

Study of AHB-137 Injection Combined With Other Hepatitis B Drugs

Who this might be right for
Chronic Hepatitis B
Ausper Biopharma Co., Ltd. 200
Not applicableUnknownNCT01533051
What this trial is testing

Prospective Observational Cohort Study for the Durability of Anti-viral Therapy in Patients With Chronic Hepatitis B

Who this might be right for
Chronic Hepatitis B
Yonsei University 100
Early research (Phase 1)Study completedNCT04123769
What this trial is testing

Study on PK of Hydronidone in Patients and Special Population

Who this might be right for
Hepatitis b & Liver Dysfunction
Beijing Continent Pharmaceutical Co, Ltd. 8
Post-approval studies (Phase 4)UnknownNCT03476083
What this trial is testing

Tenofovir Disoproxil Fumarate in Combination of Hepatitis B Vaccine for Preventing Hepatitis B Vertical Transmission

Who this might be right for
Hepatitis B InfectionCongenital MalformationBirth Defect+2 more
New Discovery LLC 280
Early research (Phase 1)UnknownNCT04480294
What this trial is testing

A Phase I Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Food Effect of Oral HRS5091 in Healthy Subjects and Chronic Hepatitis B Patients

Who this might be right for
Chronic Hepatitis B
Jiangsu HengRui Medicine Co., Ltd. 108
Testing effectiveness (Phase 2)Ended earlyNCT00040144
What this trial is testing

Safety and Antiviral Study of ACH126, 433 (b-L-Fd4C) in Adults With Lamivudine-resistant Chronic Hepatitis B

Who this might be right for
Chronic Hepatitis B
Alexion Pharmaceuticals, Inc. 85
Not applicableUnknownNCT04980664
What this trial is testing

Effort to Narrow the Gap Between in Accordance With Guidelines and Consent to Treat CHB Population in East of China

Who this might be right for
Chronic Hepatitis b
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School 2,000
Large-scale testing (Phase 3)UnknownNCT01270165
What this trial is testing

Lamivudine Plus Adefovir Versus Telbivudine Plus Adefovir in Lamivudine Resistant Chronic Hepatitis B

Who this might be right for
Chronic Hepatitis B
Yonsei University 110
Post-approval studies (Phase 4)UnknownNCT01833611
What this trial is testing

Entecavir for Chronic Hepatitis B Patients With Persistently Normal ALT

Who this might be right for
Chronic Hepatitis
National Cheng-Kung University Hospital 130
Large-scale testing (Phase 3)Study completedNCT00410202
What this trial is testing

Entecavir Plus Adefovir Combination Therapy Versus Entecavir Monotherapy vs Therapy With Adefovir Plus Lamivudine for Chronic Hepatitis B Infected Subjects With Lamivudine-resistant Virus

Who this might be right for
Hepatitis B, Chronic
Bristol-Myers Squibb 629
Not applicableStudy completedNCT01813487
What this trial is testing

Study of the Immunogenicity and Efficacy of HBsAg Vaccine in Combination With Standard Antiviral Therapy With HB110E

Who this might be right for
Chronic Hepatitis B
Genexine, Inc. 6
Not applicableUnknownNCT03539016
What this trial is testing

Observational Study on Pregnant Women With Chronic Hepatitis B and Their Infants

Who this might be right for
Hepatitis B, Chronic
Nanfang Hospital, Southern Medical University 1,000
Testing effectiveness (Phase 2)Study completedNCT04365933
What this trial is testing

The Oral Farnesoid X Receptor Modulator EYP001a to Assess Its Safety and Anti-viral Effect in Chronic Hepatitis B Patients in Combination With Pegylated Interferon alpha2a Alone and With Entecavir

Who this might be right for
Hepatitis B, Chronic
Enyo Pharma 20
Not applicableEnrolling By InvitationNCT07298577
What this trial is testing

Use of Gender, Age, Alfa-fetoprotein (AFP), and Des-gamma-carboxyprothrombin (PIVKA-II) or GAAD Score in Addition to Ultrasound for Surveillance of People At-risk for Developing Hepatocellular Carcinoma in Asia in Order to Detect Early Liver Cancer

Who this might be right for
Liver CirrhosisHepatitis B, ChronicHepatitis C, Chronic+1 more
Siriraj Hospital 2,100
Next Page